Both Pfizer, Moderna vaccines effective on B.1.617 COVID-19 strain: US Study
Both Pfizer, Moderna vaccines effective on B.1.617 COVID-19 strain: US Study By Reena Bhardwaj | Updated: May 19, 2021 11:35 IST Washington [US], May 19 (ANI): COVID-19 vaccines developed by Pfizer and Moderna work against B.1.617 variant of the virus that was first identified in India, according to a new study. The study shows that the newly identified SARS-CoV-2 variants identified in India are neutralised well by antibodies in individuals vaccinated with both vaccines. "This finding predicts that even though the new variants are highly transmissible, v...